Related Experiment Video
Updated: May 25, 2026
08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Decreased osteoclastogenesis in serotonin-deficient mice
Yasmine Chabbi-Achengli1, Amélie E Coudert, Jacques Callebert
1Institut National de la Santé et de la Recherche Médicale U606, Hôpital Lariboisière, 75010 Paris, France.
Summary
Peripheral serotonin, produced by tryptophan hydroxylase-1 (TPH1), plays a crucial role in bone remodeling. TPH1 knockout mice show reduced bone resorption, indicating serotonin
Area of Science:
- Bone biology and endocrinology
- Cellular and molecular physiology
- Pharmacology and drug discovery
Background:
- Peripheral serotonin, synthesized by tryptophan hydroxylase-1 (TPH1), has diverse physiological roles.
- Recent debate exists regarding serotonin's impact on bone density and remodeling.
- Investigating TPH1 knockout mice provides insight into serotonin's skeletal functions.
Purpose of the Study:
- To investigate the role of peripheral serotonin in bone remodeling in TPH1 knockout mice.
- To determine if serotonin's effect on bone resorption is cell-autonomous.
- To elucidate the mechanisms by which serotonin influences osteoclastogenesis.
Main Methods:
- Utilized TPH1 knockout mice (TPH1-/-) at different ages.
- Assessed bone resorption using biochemical markers and bone histomorphometry.
- Performed bone marrow transplantation experiments.
- Cultured bone marrow cells and analyzed osteoclast differentiation.
- Investigated the effects of serotonin supplementation and receptor antagonists (SB224289, ketanserin).
Main Results:
- TPH1 knockout mice exhibited significantly decreased bone resorption.
- Bone resorption reduction in TPH1 knockout mice was cell-autonomous.
- Fewer osteoclasts were generated from TPH1 knockout precursors.
- Serotonin supplementation rescued osteoclast differentiation.
- Osteoclast precursors express TPH1 and synthesize serotonin.
- Inhibition of serotonin receptors 1B and 2A reduced osteoclast numbers.
Conclusions:
- Peripheral serotonin, via TPH1, locally influences bone remodeling.
- Serotonin amplifies the osteoclastogenic effect of RANKL.
- Osteoclast precursors are a source of serotonin within the bone microenvironment.
- Targeting serotonin signaling pathways may offer novel therapeutic strategies for bone diseases.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...